My Treatment Approach: Recent Advances in the Treatment of Multiple Myeloma in Early Relapse

Brea Lipe, MD, and Peter Forsberg, MD, discuss updates in the treatment of R/R multiple myeloma, and present two hypothetical patient profiles to show how recent data can be incorporated into clinical practice.

EP. 1: Patient Profile 1: A 63-Year-Old Female with Relapsed Multiple Myeloma

August 18th 2022

Brea Lipe, MD, and Peter Forsberg, MD, present the profile of a woman with multiple myeloma in early relapse and discuss their treatment strategy.

EP. 2: Treatment Options for Patients with Multiple Myeloma in Early Relapse

August 18th 2022

An overview of the available treatment options in relapsed/refractory multiple myeloma.

EP. 3: IKEMA Trial of Isatuximab plus Carfilzomib and Dexamethasone in R/R MM

August 25th 2022

Dr Peter Forsberg reviews clinical trial data on a triplet treatment regimen for relapsed/refractory multiple myeloma.

EP. 4: Clinical Implications of the IKEMA Trial in R/R MM

August 25th 2022

Dr Forsberg details the safety data and toxicity management strategies of the IKEMA clinical trial.

EP. 5: Selecting the Appropriate Patients With MM for Treatment With Isa-Kd

September 1st 2022

Oncologists debate which patient populations most benefit from isatuximab plus carfilzomib and dexamethasone.

EP. 6: Treatment of Patients With MM and High-Risk Cytogenetics

September 1st 2022

Dr Brea Lipe explains at what stages she orders genetic testing in patients with relapsed/refractory multiple myeloma and how she approaches the treatment of patients with high-risk cytogenetics.

EP. 7: Patient Profile 2: A 76-Year-Old Female with R/R MM

September 8th 2022

Brea Lipe, MD, and Peter Forsberg, MD, present the profile of a woman with relapsed/refractory multiple myeloma and share their opinions of the treatment regimen.

EP. 8: CANDOR Trial of Daratumumab Plus Carfilzomib and Dexamethasone in R/R MM

September 8th 2022

Brea Lipe, MD, and Peter Forsberg, MD, review the results of the CANDOR trial evaluating DARA-Kd regimen in R/R multiple myeloma.

EP. 9: Selecting Patients for Treatment With DARA-Kd

September 15th 2022

Peter Forsberg, MD, offers insight into which patients with multiple myeloma are most suitable for treatment with the DARA-Kd regimen.

EP. 10: Sequencing Therapies in Patients With R/R MM

September 15th 2022

Drs Forsberg and Lipe discuss strategies for sequencing therapies in relapsed/refractory multiple myeloma.